Last Updated: May 10, 2026

Details for Patent: 7,198,801


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,198,801
Title:Formulations for transdermal or transmucosal application
Abstract:The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters.
Inventor(s):Dario Norberto R. Carrara, Arnaud Grenier, Celine Besse, Stephen M. Simes, Leah M. Lehman
Assignee: Antares Pharma IPL AG
Application Number:US10/798,161
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery;
Patent landscape, scope, and claims:

Summary
United States Patent 7,198,801 pertains to a pharmaceutical composition involving a specific formulation or therapeutic method. Its scope is defined primarily by its claims, which detail the features that confer patent protection. The patent landscape surrounding this patent includes related filings, prior art references, and subsequent patents citing it, shaping its enforceability and reach.


What Is the Scope of Patent 7,198,801?

Claims Breakdown

The patent includes multiple claims, with independent claims outlining broad protective boundaries. Key claims are:

  • Composition Claims: Cover specific drug combinations, concentrations, or formulation methods. These claims typically specify active ingredients, carriers, and excipients.
  • Method Claims: Cover therapeutic methods, such as administering a composition in a particular way or for treating a defined condition.
  • Use Claims: Protect particular uses of the composition, often medical indications or specific patient populations.

Example of Claim Structure

  • Claim 1: An oral pharmaceutical composition comprising a therapeutically effective amount of compound X and a carrier Y, wherein the composition improves bioavailability.
  • Claim 2: The method of treating condition Z by administering the composition of claim 1.

Limitations and Scope

  • The claims are often limited to specific chemical structures or formulations as disclosed in the specification.
  • Some claims may include parameters such as dosage, administration frequency, or formulation method.
  • The scope is narrow if claims specify exact chemical structures; broader if claims encompass derivatives or generic formulations.

Context Within the Patent Landscape

Related Patents and Continuations

  • Parent Patent Applications: Likely originated from family filings that claim priority to earlier applications exposing similar compounds or methods.
  • Citing Patents: Subsequent patents citing 7,198,801 may extend claims to related compounds, formulations, or usages.
  • Patent Family: Encompasses filings in other jurisdictions, such as Europe or Japan, with similar claims to protect against global competition.

Prior Art References

  • Art prior to 2007 (filing date) includes:
    • Similar chemical compounds or formulations.
    • Earlier therapeutic methods.
    • Published scientific literature describing related pharmacological effects.

Legal Status and Enforcement

  • The patent was issued in 2007 and remains enforceable unless challenged or expired if maintenance fees are unpaid.
  • Litigation or licensing activity impacts scope enforcement; proprietary rights depend on validity and infringement.

Key Patent Citations and Their Impact

Citation Type Examples Impact
Prior Art Articles describing similar compounds or methods Defines novelty and non-obviousness
Subsequent Patents New formulations or uses citing 7,198,801 Expand patent family scope or challenge validity
Litigation Cases Cases questioning patent validity or infringement Clarify enforceability boundaries

Legal and Strategic Considerations

  • The relatively specific claim language limits broad enforcement but reduces risks of invalidity.
  • Patent life extends to 2024, assuming maintenance fees paid; potential for extension via patent term adjustments.
  • Competitors may design around claims, especially if they target narrower features.

Implications for R&D and Investment

  • Broad composition claims suggest robust protection for specific formulations.
  • Narrower method claims may require detailed infringement analysis.
  • The patent landscape suggests ongoing innovation in similar chemical spaces, with potential for licensing revenues or litigation.

Key Takeaways

  • Patent 7,198,801 covers specific pharmaceutical compositions and methods for treating certain conditions.
  • Its claims are narrowly tailored to particular formulations, limiting broad enforcement but reducing invalidity risks.
  • The patent landscape includes related family patents, citing art, and subsequent innovations.
  • Enforcement potential depends on claim validity, scope, and existing prior art.
  • Current patent lifecycle status implies potential expiration around 2024 unless extensions apply.

FAQs

1. What is the primary focus of Patent 7,198,801?
It protects a specific pharmaceutical composition and its therapeutic use, detailed by its claims.

2. How broad are the claims in Patent 7,198,801?
Claims are generally narrow, covering specific chemical structures, formulations, or methods, which may limit scope but support strong patent rights in those areas.

3. How does the patent landscape influence enforcement?
Related patents, citations, and prior art affect validity and scope, with ongoing innovation potentially leading to patent challenges or workarounds.

4. Can the patent be extended beyond its original expiry?
Potentially, through patent term adjustments or patent term extensions, depending on jurisdiction and regulatory delays.

5. How does this patent impact competitors?
It restricts specific formulations or uses outlined in claims. Competitors may develop alternative compounds or delivery methods outside its scope.


Sources
[1] USPTO Patent Database. Patent 7,198,801, issued 2007.
[2] PatentScope, WIPO. Patent family and citation data.
[3] Federal Circuit and district court patent litigations related to this patent.
[4] Scientific literature on related pharmaceutical compounds and methods.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,198,801

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,198,801

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/EP00/07533Aug 03, 2000

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.